Welcome to our dedicated page for Ehealth SEC filings (Ticker: EHTH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The eHealth, Inc. (NASDAQ: EHTH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a public company in the insurance agencies and brokerages industry, eHealth uses SEC filings to report material events, financial results, governance changes, and capital structure developments that are relevant to investors evaluating EHTH stock.
eHealth regularly files current reports on Form 8-K to announce significant developments. Recent 8-K filings describe quarterly financial results, including press releases for the second and third quarters of a fiscal year, and provide information about the company’s financial condition. Other 8-Ks document amendments to credit agreements, such as an extension of the maturity date of a term loan credit agreement with Blue Torch Finance LLC and the entry into a new asset-based revolving credit facility with Manulife | Comvest Credit Partners, along with the use of proceeds to repay existing debt and support strategic initiatives.
Filings also address corporate governance and compensation matters. eHealth has reported on amendments and restatements of its bylaws, including changes to meeting notice deadlines, definitions relevant to principal competitors, and provisions related to indemnification and insurance for directors, officers, employees and agents. Other filings discuss the approval and amendment of equity incentive plans, inducement and equity awards for executives and directors, and the results of stockholder votes on director elections, executive compensation, and plan amendments.
Leadership changes and board composition are another focus of eHealth’s SEC reports. Form 8-K filings describe CEO transition arrangements, the appointment of a new chief executive officer, related severance and compensation agreements, and the resignation and appointment of directors, including those designated under an investment agreement with a preferred stock investor. These disclosures help investors understand how management and board oversight are evolving.
On Stock Titan, eHealth’s SEC filings are paired with AI-powered summaries that help explain the contents of lengthy documents such as 8-Ks and, where available, annual reports on Form 10-K, quarterly reports on Form 10-Q, and proxy statements. Real-time updates from EDGAR ensure that new filings, including any insider transaction reports on Form 4 or other material disclosures, are quickly reflected. The AI summaries highlight key points, such as changes in capital structure, governance updates, and important risk or operational information, allowing users to review the implications for EHTH without reading every line of each filing.
By using this filings page, investors can efficiently review eHealth’s regulatory history, track recurring themes in its disclosures, and connect filing information with the company’s news releases and business description. This context can support deeper analysis of eHealth’s financial performance, risk profile, and strategic direction as presented in its official SEC documents.
eHealth, Inc. director and Chief Executive Officer Derrick A. Duke reported an open-market purchase of 187,969 shares of common stock at $1.38 per share on February 27, 2026. Following this transaction, he directly owns 487,969 shares of eHealth common stock.
eHealth, Inc. reported another year of improved profitability for 2025 while issuing a cautious outlook for 2026. Full-year 2025 revenue reached $554.0 million, up 4%, with GAAP net income rising to $40.0 million from $10.1 million and adjusted EBITDA increasing 40% to $97.3 million.
Fourth-quarter 2025 revenue was $326.2 million, up 4% year over year, while GAAP net income declined to $87.2 million from $97.5 million, mainly due to a higher effective tax rate. Q4 adjusted EBITDA improved 10% to $132.9 million, and the adjusted EBITDA margin increased to 41%.
The company ended 2025 with a $1.1 billion commissions receivable balance, up 12%, and enhanced liquidity by replacing a $70.0 million term loan with a $125.0 million asset-backed revolving credit facility maturing in 2028. For 2026, eHealth guides to revenue of $405–$445 million, GAAP net income of $8–$25 million, adjusted EBITDA of $55–$75 million, and operating cash flow between -$10 million and $12 million, prioritizing cash generation and margin over near-term growth.
eHealth, Inc. ownership amendment: 8 Knots entities and Scott Green report beneficial ownership as of
Breakdown: 8 Knots Fund holds 1,140,237 shares (
eHealth, Inc. received a Schedule 13G reporting that Palo Alto Investors LP, its general partner PAI LLC, and co-managers Patrick Lee, MD and Anthony Joonkyoo Yun, MD beneficially own 1,531,429 shares of eHealth common stock, or 4.98% of the class, as of 12/31/2025.
The filing shows no sole voting or dispositive power, and shared voting and dispositive power over all reported shares. The securities are held in the ordinary course of PAI’s investment advisory business, and the filers state they are not seeking to change or influence control of eHealth and disclaim group status and beneficial ownership beyond their pecuniary interests.
eHealth, Inc.’s Chief Financial Officer John Joseph Dolan reported a tax-related share disposition. On 02/10/2026, 1,738 shares of eHealth common stock were withheld at $1.98 per share to satisfy a tax withholding obligation. After this transaction, Dolan directly beneficially owned 183,755 common shares.
eHealth, Inc. Chief Revenue Officer Michelle Marie Barbeau reported a routine share withholding related to taxes. On 01/10/2026, 379 shares of eHealth common stock were withheld at a price of $4 per share in a transaction coded "F," which indicates shares withheld to satisfy tax withholding obligations. After this non-open-market transaction, Barbeau beneficially owned 248,046 shares of eHealth common stock directly.
eHealth, Inc.'s Chief Financial Officer John Joseph Dolan reported a tax-related share withholding. On 01/10/2026, 539 shares of eHealth common stock were withheld at a price of $4 per share to satisfy a tax withholding obligation. After this transaction, Dolan beneficially owned 185,493 shares of eHealth common stock, all held directly. The transaction is coded as "F," indicating it relates to the payment of taxes in connection with equity compensation rather than an open-market sale.
eHealth, Inc. insider Gavin G. Galimi, the company’s SVP, General Counsel & Secretary, reported a routine share withholding related to taxes. On 01/10/2026, 966 shares of eHealth common stock were withheld at a price of $4.00 per share, as noted in the footnote stating this represented the withholding of shares to satisfy tax withholding obligations. After this transaction, Galimi beneficially owned 230,742 shares of eHealth common stock directly.
eHealth, Inc. reported that its board approved amended and restated bylaws effective immediately. The changes adjust stockholder meeting notice deadlines to Eastern Time, set a timeline for the company to provide a director nominee questionnaire within five business days of request, define the term “principal competitor” for certain stockholder disclosure requirements, and clarify the company’s ability to maintain insurance for directors, officers, employees and agents under Delaware law, along with other ministerial updates.
The company also issued a press release on December 18, 2025 with preliminary operational results for its annual enrollment period and updated guidance ranges for the fiscal year ending December 31, 2025, describing its AEP performance as strong.